Neuropeptide YY1 Receptors-mediated Increase in Intracellular Ca2+ Concentration Via Phospholipase C-dependent Pathway in Porcine Aortic Smooth Muscle Cells
Overview
Authors
Affiliations
In porcine aortic smooth muscle cells, neuropeptide Y (NPY) stimulates mobilization of CA(2+) from intracellular store sites via Y1 receptors. However, it has been debated whether or not Ca(2+) mobilization by Y1 receptors depends on the generation of inositol 1,4,5-trisphosphate [Ins(1,4,5)P3] following activation of phospholipase C. To examine this question, we studied the effect of U73122, an inhibitor of phospholipase C-mediated inositol phosphate accumulation on the NPY-induced rise in cytosolic free Ca(2+) concentration ([Ca(2+)]i) in comparison with that on angiotensin II (AII)-induced [Ca(2+)]i increase, which is dependent on Ins(1,4,5)P3 generation. Digital-imaging microscopy study using the Ca(2+)-sensitive dye fura-2 revealed that application of AII induced a rapid but transient [Ca(2+)]i increase in a single cell, arising from intracellular calcium stores. Application of NPY to the same cell induced a [Ca(2+)]i rise with a pattern similar to that induced by AII. AII increased the formation of Ins(1,4,5)P3 by about 3.0 fold, while the NPY-induced [Ca(2+) formation was very small. U73122 completely inhibited not only Ins(1,4,5)P3 synthesis, but also Ca(2+) mobilization induced by either agonist. The effect of U73122 on the NPY-induced Ca(2+)i increase was about 10-fold more potent that on the AII-induced one. U73343, an inactive analog of U733343, had no influence on any of the AII- and NPY-mediated effects. Herbimycin A completely inhibited the platelet-derived growth factor-induced [Ca(2+]i increase but had no effect on the NPY-induced [Ca(2+)]i increase, indicating that phospholipase C-gamma is not involved in the NPY effect. These results suggest that NPY-induced Ca2+ mobilization from intracellular stores in porcine smooth muscle cells is secondary to the very small generation of Ins(1,4,5)P3 following stimulation of phospholipase C-beta, which may account for the hypersensitivity of the NPY effect to U73122.
Neural control of coronary artery blood flow by non-adrenergic and non-cholinergic mechanisms.
Shanks J, Thomson S, Ramchandra R Exp Physiol. 2023; 109(12):2011-2016.
PMID: 37029787 PMC: 11607609. DOI: 10.1113/EP090917.
NPY/Y₁ receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertension.
Crnkovic S, Egemnazarov B, Jain P, Seay U, Gattinger N, Marsh L Br J Pharmacol. 2014; 171(16):3895-907.
PMID: 24779394 PMC: 4128051. DOI: 10.1111/bph.12751.
Pons J, Kitlinska J, Jacques D, Perreault C, Nader M, Everhart L Can J Physiol Pharmacol. 2008; 86(7):438-48.
PMID: 18641693 PMC: 2923562. DOI: 10.1139/y08-054.
Prieto D, Buus C, Mulvany M, Nilsson H Br J Pharmacol. 2000; 129(8):1689-99.
PMID: 10780975 PMC: 1572012. DOI: 10.1038/sj.bjp.0703256.
Ferrier L, Segain J, Pacaud P, Cherbut C, Loirand G, Galmiche J Gut. 2000; 46(3):370-5.
PMID: 10673299 PMC: 1727869. DOI: 10.1136/gut.46.3.370.